Canaccord lowered the firm’s price target on Voyager Therapeutics (VYGR) to $12 from $14 and keeps a Buy rating on the shares. The firm said they reported its 4Q24 results showing Operating ...

NEW YORK, NY / ACCESS Newswire / March 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Voyager Therapeutics, Inc ("Voyager" or the "Company") (NASDAQ:VYGR). Such ...

When thinking of a way to give back to the community, Voyager RV thought to themselves they would get their customers involved as well. That sparked the Voyager Cares initiative. In this, customers ...

A total of 1088 guests have reviewed Voyager of the Seas, giving it a rating of 4.1 on a scale of 1-5. Family friendly but not infant friendly Mar 15th, 2025 Not totally family friendly!